Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
EM

EMBC

Market Closed

Embecta Corp.

NASDAQHealthcareMedical - Instruments & Supplies
US
1.85K employees
CEO: Devdatt Kurdikar
Founded: 2022
$5.80
+$0.00(+NaN%)
Market Cap
344.10M
Beta
0.85
52W Range
N/A
Dividend Yield
5.52%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Based on PERT weighted analysis (confidence: high), the fair value is $36.55, implying 530.2% upside from current levels. The stock appears significantly undervalued. Financial health scores indicate solid fundamentals (3.8/5). Monte Carlo analysis shows low downside risk (0% of scenarios below current price). Overall, this suggests a compelling buying opportunity at current prices.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore EMBC

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

EMBC in the Healthcare

Small Cap
Healthcare

Browse sector stocks →

Medical - Instruments & Supplies

Browse industry stocks →